BTA798
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BTA798, covering 2017-06-01 to 2017-06-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection [Phase 2]